MLchartDataset catalogue

Rapamycin

Term · Oncology and biomedicine · MLC-T-ONC-007214

A drug used to keep the body from rejecting organ and bone marrow transplants. Rapamycin blocks certain white blood cells that can reject foreign tissues and organs. It also blocks a protein that is involved in cell division. It is a type of antibiotic, a type of immunosuppressant, and a type of serine/threonine kinase inhibitor. Rapamycin is now called sirolimus.

Table 1. Record
IdentifierMLC-T-ONC-007214
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007214",
  "term": "Rapamycin",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to keep the body from rejecting organ and bone marrow transplants. Rapamycin blocks certain white blood cells that can reject foreign tissues and organs. It also blocks a protein that is involved in cell division. It is a type of antibiotic, a type of immunosuppressant, and a type of serine/threonine kinase inhibitor. Rapamycin is now called sirolimus.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/rapamycin/"
}

Record 14,066 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.